- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2021 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Focus on Rheumatoid Arthritis
The Rheumatology Network rheumatoid arthritis clinical focus page provides information on the latest rheumatoid arthritis news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for rheumatoid arthritis drugs.
Cardiovascular Disease Prevention Remains Lackluster in Patients With Rheumatoid Arthritis and Diabetes Mellitus
July 28, 2021
While prevention of atherosclerotic cardiovascular disease (ASCVD) in patients with rheumatoid arthritis (RA) is advocated by recent recommendations, ASCVD prevention in patients with RA was underwhelming, according to an international audit.
Low Prevalence of Anti-SSA/B in Women With Rheumatoid Arthritis Wishing to Conceive
July 15, 2021
Given the low prevalence of anti-Sjögren's-syndrome-related antigen A (anti-SSA) and anti–Sjögren's-syndrome-related antigen B (anti-SSB) in women with rheumatoid arthritis who would like to conceive, intensive echocardiographic screening may not be necessary.
Autoimmune Rheumatic Disease Does Not Influence Immune Response Against COVID-19
July 14, 2021
Research indicates that patients with autoimmune rheumatic diseases (AIRD) did not differ from the general population in terms of protective antibody responses against COVID-19.
Erectile Dysfunction Decreases Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis
July 14, 2021
Surprisingly, patients with rheumatoid arthritis and erectile dysfunction had a significantly decreased rate of myocardial infarction, heart failure, and death when compared with patients with rheumatoid arthritis alone.
Claire Daien, MD: ABX464 Treatment for Rheumatoid Arthritis
July 07, 2021
Claire Daien, MD, discusses the safety and efficacy of ABX464, the primary and secondary endpoints, and what differentiates the medication from other rheumatoid arthritis therapies.
Food is Mood
June 22, 2021
The enteric nervous system (ENS) is comprised of the lining of the esophagus, stomach, small intestine, and colon and is estimated to include 500 million neurons and 40 neurotransmitters directly connected to mood and cognition. The newest research suggests that 95% of available serotonin and 50% of bio-available dopamine is produced in the ENS.
Mehret Birru Talabi, MD, PhD: Medication Decision-Making During Pregnancy and Lactation Among Women With Inflammatory Arthritis
June 17, 2021
Rheumatology Network sat down with Mehret Birru Talabi, MD, PhD, to discuss the recent study published in ACR Open Rheumatology entitled, “Tough choices: Exploring medication decision-making during pregnancy and lactation among women with inflammatory arthritis.”
Rheumatology Network's Top 5: June 11, 2021
June 11, 2021
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 11, 2021.
Liana Fraenkel, MD, MPH: ACR 2021 Treatment Guidelines for Rheumatoid Arthritis
June 11, 2021
Liana Fraenkel, MD, MPH, discusses the recent updates to the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis, for which she served as part of the Core Leadership Team.
Eugen Feist, MD: Olokizumab Emerges as Promising Therapy for Rheumatoid Arthritis
June 10, 2021
Rheumatology Network sat down with Eugen Feist, MD, to discuss the recent olokizumab data including the therapeutic prospects for olokizumab, its unique biologic mode of action, and the clinical significance of the phase III studies.